FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204131121> ?p ?o ?g. }

• W3204131121 abstract "Abstract Background Since fall 2019, SARS-CoV-2 spread world-wide, causing a major pandemic with estimated ~ 220 million subjects affected as of September 2021. Severe COVID-19 is associated with multiple organ failure, particularly of lung and kidney, but also grave neuropsychiatric manifestations. Overall mortality reaches > 2%. Vaccine development has thrived in thus far unreached dimensions and will be one prerequisite to terminate the pandemic. Despite intensive research, however, few treatment options for modifying COVID-19 course/outcome have emerged since the pandemic outbreak. Additionally, the substantial threat of serious downstream sequelae, called ‘long COVID’ and ‘neuroCOVID’, becomes increasingly evident. Main body of the abstract Among candidates that were suggested but did not yet receive appropriate funding for clinical trials is recombinant human erythropoietin. Based on accumulating experimental and clinical evidence, erythropoietin is expected to (1) improve respiration/organ function, (2) counteract overshooting inflammation, (3) act sustainably neuroprotective/neuroregenerative. Recent counterintuitive findings of decreased serum erythropoietin levels in severe COVID-19 not only support a relative deficiency of erythropoietin in this condition, which can be therapeutically addressed, but also made us coin the term ‘hypoxia paradox’. As we review here, this paradox is likely due to uncoupling of physiological hypoxia signaling circuits, mediated by detrimental gene products of SARS-CoV-2 or unfavorable host responses, including microRNAs or dysfunctional mitochondria. Substitution of erythropoietin might overcome this ‘hypoxia paradox’ caused by deranged signaling and improve survival/functional status of COVID-19 patients and their long-term outcome. As supporting hints, embedded in this review, we present 4 male patients with severe COVID-19 and unfavorable prognosis, including predicted high lethality, who all profoundly improved upon treatment which included erythropoietin analogues. Short conclusion Substitution of EPO may—among other beneficial EPO effects in severe COVID-19—circumvent downstream consequences of the ‘hypoxia paradox’. A double-blind, placebo-controlled, randomized clinical trial for proof-of-concept is warranted." @default.
• W3204131121 created "2021-10-11" @default.
• W3204131121 creator A5024783922 @default.
• W3204131121 creator A5034115336 @default.
• W3204131121 creator A5044746918 @default.
• W3204131121 creator A5045838730 @default.
• W3204131121 creator A5059455072 @default.
• W3204131121 creator A5061926369 @default.
• W3204131121 creator A5068739017 @default.
• W3204131121 creator A5069268891 @default.
• W3204131121 creator A5071802899 @default.
• W3204131121 creator A5086289939 @default.
• W3204131121 date "2021-09-26" @default.
• W3204131121 modified "2023-10-17" @default.
• W3204131121 title "Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues" @default.
• W3204131121 cites W1584945551 @default.
• W3204131121 cites W1968806449 @default.
• W3204131121 cites W2013177525 @default.
• W3204131121 cites W2016528779 @default.
• W3204131121 cites W2027312796 @default.
• W3204131121 cites W2029974888 @default.
• W3204131121 cites W2036743595 @default.
• W3204131121 cites W2037656344 @default.
• W3204131121 cites W2103255946 @default.
• W3204131121 cites W2106453685 @default.
• W3204131121 cites W2111144499 @default.
• W3204131121 cites W2115406568 @default.
• W3204131121 cites W2125569100 @default.
• W3204131121 cites W2159161978 @default.
• W3204131121 cites W2168867226 @default.
• W3204131121 cites W2336116827 @default.
• W3204131121 cites W2483120162 @default.
• W3204131121 cites W2746250549 @default.
• W3204131121 cites W2762453060 @default.
• W3204131121 cites W2959624934 @default.
• W3204131121 cites W3001897055 @default.
• W3204131121 cites W3004280078 @default.
• W3204131121 cites W3004318991 @default.
• W3204131121 cites W3009163926 @default.
• W3204131121 cites W3011701533 @default.
• W3204131121 cites W3012421327 @default.
• W3204131121 cites W3015863623 @default.
• W3204131121 cites W3016053327 @default.
• W3204131121 cites W3016127017 @default.
• W3204131121 cites W3016661132 @default.
• W3204131121 cites W3018631425 @default.
• W3204131121 cites W3019538888 @default.
• W3204131121 cites W3020300207 @default.
• W3204131121 cites W3020735691 @default.
• W3204131121 cites W3021583712 @default.
• W3204131121 cites W3022285953 @default.
• W3204131121 cites W3022539327 @default.
• W3204131121 cites W3023873927 @default.
• W3204131121 cites W3024126428 @default.
• W3204131121 cites W3026008037 @default.
• W3204131121 cites W3031869734 @default.
• W3204131121 cites W3032921852 @default.
• W3204131121 cites W3033090821 @default.
• W3204131121 cites W3035063822 @default.
• W3204131121 cites W3035094564 @default.
• W3204131121 cites W3035215875 @default.
• W3204131121 cites W3036779511 @default.
• W3204131121 cites W3040794648 @default.
• W3204131121 cites W3041493976 @default.
• W3204131121 cites W3043015313 @default.
• W3204131121 cites W3044033898 @default.
• W3204131121 cites W3046055171 @default.
• W3204131121 cites W3046101830 @default.
• W3204131121 cites W3048348288 @default.
• W3204131121 cites W3048503737 @default.
• W3204131121 cites W3070973952 @default.
• W3204131121 cites W3087991293 @default.
• W3204131121 cites W3088609942 @default.
• W3204131121 cites W3090344202 @default.
• W3204131121 cites W3092499620 @default.
• W3204131121 cites W3094854996 @default.
• W3204131121 cites W3096975836 @default.
• W3204131121 cites W3101105393 @default.
• W3204131121 cites W3102327145 @default.
• W3204131121 cites W3106791064 @default.
• W3204131121 cites W3110466220 @default.
• W3204131121 cites W3110926944 @default.
• W3204131121 cites W3112902030 @default.
• W3204131121 cites W3114155216 @default.
• W3204131121 cites W3115058895 @default.
• W3204131121 cites W3118903662 @default.
• W3204131121 cites W3120387768 @default.
• W3204131121 cites W3120709764 @default.
• W3204131121 cites W3120750707 @default.
• W3204131121 cites W3120873513 @default.
• W3204131121 cites W3122529148 @default.
• W3204131121 cites W3126232912 @default.
• W3204131121 cites W3127490907 @default.
• W3204131121 cites W3127525338 @default.
• W3204131121 cites W3128051785 @default.
• W3204131121 cites W3128292824 @default.
• W3204131121 cites W3131995220 @default.
• W3204131121 cites W3132728920 @default.
• W3204131121 cites W3133745198 @default.
• W3204131121 cites W3133757346 @default.

• next